Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Eric Low

Open access research partnership to ‘crowdsource’ new myeloma drugs

January 27, 2016 Research and Development Myeloma UK, Structural Genomics Consortium, collaboration, eric low, myeloma, partnership

Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to find new drug targets …
News
merck_vib_m_org_1_rbvyvm_4c-01

New biopharma heads for Merck in North America and China

January 27, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Gary Zieziula, Mark Horn, Merck

Merck has made two appointments in its biopharma business: Gary Zieziula will lead Merck’s biopharma business in North America and …
Appointment

Is bioscience still getting lost in translation?

January 27, 2016 Research and Development CASMI, Centre for Sustainable Medical Innovation, Professor Richard Barker, R&D, bioscience

After several years of anguish about pharmaceutical pipelines, R&D productivity seems to be picking up.New medicines and cell and gene …
Feature

Pharma ‘forced to innovate in patient recruitment and retention’

January 27, 2016 Research and Development Tufts, clinical trials, patient recruitment, patient retention

The ‘critical need’ to improve recruitment and retention in clinical trials is driving pharma to create a “structural change in …
News
Jardiance

FDA reviews Jardiance as cardiovascular diabetes treatment

January 27, 2016 Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance

The FDA has accepted Boehringer Ingelheim and Eli Lilly’s supplemental New Drug Application for their diabetes drug Jardiance to be …
News
NHS NICE logo

NICE recommends six drugs in final guidance

January 27, 2016 Research and Development, Sales and Marketing NHS, NICE

NICE has published final recommendations approving drug treatments for ovarian cancer, prostate cancer, multiple myeloma, gastric cancer and idiopathic pulmonary …
News

Johnson & Johnson hit by fall in 2015 sales

January 27, 2016 Research and Development, Sales and Marketing Janssen, Johnson and Johnson, financial results, revenue, sales

Full year sales at the healthcare giant Johnson & Johnson fell by 6% in 2015, to just over $70 billion, …
News

NICE backs biosimilars with arthritis drug endorsements

January 27, 2016 Research and Development, Sales and Marketing DMARDs, NICE, biosimilars, rheumatoid arthritis

NICE has published updated final guidance recommending seven biological disease modifying drugs (DMARDs) for treatment of severe rheumatoid arthritis which …
News
philippe_cotrel

Avacta appoints Philippe Cotrel as chief commercial officer

January 25, 2016 Manufacturing and Production, Research and Development Avacta

Cotrel joins Avacta from Abcam, where he held the role of commercial operations director.He will lead the Group’s commercial strategy …
Appointment
matthewpfeffer_sm

New chief exec at MannKind

January 25, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Alfred Mann, Duane DeSisto, Insulet, Mannkind, Matthew Pffefer

The board of directors of MannKind have appointed Matthew Pfeffer as chief executive of MannKind.He replaces Alfred Mann who has …
Appointment

AbbVie VP joins UCB Pharma

January 25, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Pascale Richetta, UCB, UCB Pharma

Pascale Richetta will join the UCB as its new head of the bone therapy patient value unit as from February …
Appointment
bruce_ponder

Cancer Research UK appoints Professor Sir Bruce Ponder as trustee

January 25, 2016 Research and Development Cancer Research UK, Professor Sir Bruce Ponder

Cancer Research UK has appointed Professor Sir Bruce Ponder as a trustee. Ponder is emeritus professor of oncology at Cambridge …
Appointment
careers

The case for leaders with scientific acumen in pharma

January 25, 2016 Medical Communications, Research and Development research and development

Pharmaceutical companies are currently undergoing fundamental, disruptive changes to conventional research and development models. This is in an attempt to …
Feature
Researcher

Big pharma and UK universities launch £40m innovation fund

January 25, 2016 Research and Development, Sales and Marketing Apollo, AstraZeneca, GSK, GlaxoSmithKline, Johnson & Johson, UCL, University College London, University of Cambridge, collaboration, imperial college london, joint venture

A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …
News
AbbVie

AbbVie and MD Anderson in cancer research partnership

January 25, 2016 Research and Development, Sales and Marketing AbbVie, MD Anderson Cancer Centre, immuno-oncology

AbbVie has announced a new partnership with The University of Texas MD Anderson Cancer Centre, using its immunotherapy platform to …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026